Topics

Givlaari, Nubeqa among Jan CHMP decisions

05:32 EST 3 Feb 2020 | PharmaTimes

The committee recommended fifteen medicines for approval at its first meeting of 2020, as well as six extensions of current indications.

Original Article: Givlaari, Nubeqa among Jan CHMP decisions

NEXT ARTICLE

More From BioPortfolio on "Givlaari, Nubeqa among Jan CHMP decisions"

Quick Search